Maternal endothelial damage as a disorder shared by early preeclampsia, late preeclampsia and intrauterine growth restriction
- PMID: 27865093
- DOI: 10.1515/jpm-2016-0178
Maternal endothelial damage as a disorder shared by early preeclampsia, late preeclampsia and intrauterine growth restriction
Abstract
Introduction: Preeclampsia (PE) and intrauterine growth restriction (IUGR) are separate disease entities that have frequently been reported as sharing the same pathogenesis. In both of them, angiogenesis disorders and generalized endothelial damage with an accompanying inflammation are the dominant symptoms. In this study, we attempted to prove that both these processes demonstrate the same profile in early PE, late PE and IUGR patients, while the only difference is in the degree of exacerbation of the lesions.
Patients, materials and methods: In 167 patients divided into four groups, three of those with early PE, late PE and IUGR and one control group, fms-like tyrosine kinase-1 (sFlt-1), placental growth factor (PlGF), high sensitive c-reactive protein (hsCRP) and fibronectin were determined. The behavior of these parameters in each of the groups was studied, and correlations between them were sought for.
Results: Higher concentrations of sFlt-1, hsCRP and fibronectin and a lower concentration of PlGF were found in the study groups compared to the control group. Significant correlations were observed between the factors concerned.
Conclusions: The higher values of disordered angiogenesis markers, endothelial damage markers and inflammatory markers both in the PE and the intrauterine growth restriction (IUGR) groups suggest the existence of shared disorders in the development of these pathologies. The correlations between disordered angiogenesis markers and endothelial damage markers argue in favor of a mutual relationship between these two processes in the development of pathologies evolving as secondary to placental ischemia. The results obtained confirm that the lesion profiles are the same in both PE and IUGR patients, which can be utilized in developing common diagnostic criteria.
Keywords: Fibronectin; IUGR; PlGF; preeclampsia; sFlt-1.
Similar articles
-
A Common Profile of Disordered Angiogenic Factor Production and the Exacerbation of Inflammation in Early Preeclampsia, Late Preeclampsia, and Intrauterine Growth Restriction.PLoS One. 2016 Oct 19;11(10):e0165060. doi: 10.1371/journal.pone.0165060. eCollection 2016. PLoS One. 2016. PMID: 27760191 Free PMC article.
-
Predictive value of sFlt-1, PlGF, sFlt-1/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37 weeks of pregnancy.Pregnancy Hypertens. 2018 Apr;12:124-128. doi: 10.1016/j.preghy.2018.04.010. Epub 2018 Apr 11. Pregnancy Hypertens. 2018. PMID: 29674192
-
Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia.Hypertens Pregnancy. 2017 May;36(2):175-185. doi: 10.1080/10641955.2017.1291673. Epub 2017 May 11. Hypertens Pregnancy. 2017. PMID: 28494189
-
An updated view on the origin and use of angiogenic biomarkers for preeclampsia.Expert Rev Mol Diagn. 2018 Dec;18(12):1053-1061. doi: 10.1080/14737159.2018.1546579. Epub 2018 Nov 14. Expert Rev Mol Diagn. 2018. PMID: 30413130 Review.
-
Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia.Am J Obstet Gynecol. 2006 Jul;195(1):40-9. doi: 10.1016/j.ajog.2005.07.049. Epub 2006 Apr 21. Am J Obstet Gynecol. 2006. PMID: 16813742 Review.
Cited by
-
Maternal Perinatal Characteristics in Patients with Severe Preeclampsia: A Case-Control Nested Cohort Study.Int J Environ Res Public Health. 2021 Nov 10;18(22):11783. doi: 10.3390/ijerph182211783. Int J Environ Res Public Health. 2021. PMID: 34831539 Free PMC article.
-
Prediction of Preeclampsia and Intrauterine Growth Restriction: Development of Machine Learning Models on a Prospective Cohort.JMIR Med Inform. 2020 May 18;8(5):e15411. doi: 10.2196/15411. JMIR Med Inform. 2020. PMID: 32348266 Free PMC article.
-
Maternal Immune Activation During Pregnancy and Obstetric Outcomes: A Population-Based Cohort Study.BJOG. 2025 Aug;132(9):1307-1318. doi: 10.1111/1471-0528.18191. Epub 2025 May 2. BJOG. 2025. PMID: 40313214 Free PMC article.
-
Endothelial dysfunction in preterm infants: The hidden legacy of uteroplacental pathologies.Front Pediatr. 2022 Nov 4;10:1041919. doi: 10.3389/fped.2022.1041919. eCollection 2022. Front Pediatr. 2022. PMID: 36405831 Free PMC article. Review.
-
Enhanced Serum Levels of sFlt1: Impact on Materno-Fetal CMV Transmission.J Clin Med. 2020 Apr 26;9(5):1258. doi: 10.3390/jcm9051258. J Clin Med. 2020. PMID: 32357516 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous